Fourth UCLH patient to be given innovative treatment for CJD
A fourth patient of University College London Hospitals NHS Foundation Trust (UCLH) is to be given a pioneering treatment for Creutzfeldt-Jakob disease (CJD) following a ruling from the Court of Protection. For further information please visit: https://www.uclh.nhs.uk/News/Pages/FourthUCLHpatienttobegiveninnovativetreatmentforCJD.aspx?fbclid=IwAR34ri4BQykPTsf4Is3MIGT152wBaRrrhxuCIrzL-9e_34RnQWN8KjKUZv4
Sixth UCLH patient to receive innovative drug for CJD
A sixth patient of University College London Hospitals NHS Foundation Trust (UCLH) is receiving an innovative treatment for Creutzfeldt-Jakob disease (CJD). In October 2018, we began treating patients with an unlicensed antibody called PRN100 which has been developed by researchers at the Medical Research Council (MRC) Prion Unit at University College London (UCL). CJD is […]
Response to the BBC Programme – ‘Mad Cow Disease: The Great British Beef Scandal”
The BBC Programme served as a timely reminder of the Bovine Spongiform Encephalopathy (BSE) outbreak, the associated variant Creutzfeldt-Jakob Disease (vCJD) diagnosed in over 170 people in the UK, and the tragic loss of so many lives to the disease. The programme focused purely on variant CJD – triggered by human consumption of BSE infected […]
Fears about a potential second wave of vCJD (Bovine Spongiform Encephalopathy (BSE))
Years after the wave of deaths caused by BSE in the 1990s, the CJD Surveillance Unit in Edinburgh have said that a second wave of cases is likely, due to variations in genetics. For further information on this story please head to the main article: https://www.mirror.co.uk/news/uk-news/mad-cow-disease-timebomb-doctors-17280396?fbclid=IwAR2RTBkQlG4LjEJFqNlwM1FvKz6JkfA5JulIse52kiqu5mx48qyfff1XY4I
UCLH is set to give two more patients treatment for CJD
The University’s treatment of Sporadic CJD started in October 2018. The first patient has been receiving treatment for two months and has not experienced any side effects to date. UCLH will now be giving the antibody treatment to a second and third patient. For further information please visit: https://www.uclh.nhs.uk/News/Pages/TwomoreUCLHpatientstoreceivepioneeringtreatmentforCJD.aspx?fbclid=IwAR32NFzmpCk0DpnDjRGhdvvloRrW9slOcXO88_f04IvLjmkNZ1qxhauY98k
Patient of University College London Hospitals NHS Foundation Trust (UCLH) to be given CJD treatment
In a world-first, a patient of University College London Hospitals NHS Foundation Trust (UCLH) is set to be given a pioneering treatment for Creutzfeldt-Jakob disease (CJD). UCLH is set to give the antibody to a patient for the first time after a judge in the Court of Protection today confirmed that it is lawful and […]
